BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1974154)

  • 21. Expansion of a lymphocyte population co-expressing T4 (CD4) and T8 (CD8) antigens in the peripheral blood of a normal adult male.
    Kay NE; Bone N; Hupke M; Dalmasso AP
    Blood; 1990 May; 75(10):2024-9. PubMed ID: 2140062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical usefulness of 111In-oxine-labeled autologous lymphocytes in kidney-graft rejection.
    Martin-Comin J; Roca M; Griñó JM; Paradell C; Caralps A
    Eur J Nucl Med; 1985; 10(7-8):308-12. PubMed ID: 3924619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of CD4+ and CD8+ T cells to graft-versus-host disease and graft-versus-leukemia reactivity after transplantation of MHC-compatible bone marrow.
    Truitt RL; Atasoylu AA
    Bone Marrow Transplant; 1991 Jul; 8(1):51-8. PubMed ID: 1833016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of lymphocyte kinetics in nasopharyngeal carcinoma with indium III oxine-labelled lymphocytes.
    Cheng PN; Shiu WC; Leung JO; Ho SK; Wong KK; Metreweli C
    Clin Exp Immunol; 1988 Dec; 74(3):398-403. PubMed ID: 3148379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of cutaneous leukemia with accumulation of In-111-oxine labeled autologous leukemic cells].
    Takagi Y; Kokubun K; Konno M; Matsuda S; Uchida T; Kariyone S
    Kaku Igaku; 1985 Nov; 22(11):1717-9. PubMed ID: 3938496
    [No Abstract]   [Full Text] [Related]  

  • 27. Migration pathways of recirculating murine B cells and CD4+ and CD8+ T lymphocytes.
    Pellas TC; Weiss L
    Am J Anat; 1990 Apr; 187(4):355-73. PubMed ID: 2141229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
    Han T
    Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
    Visser L; Rutgers B; Diepstra A; van den Berg A; Sattarzadeh A
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term depletion of naive T cells in patients treated for Hodgkin's disease.
    Watanabe N; De Rosa SC; Cmelak A; Hoppe R; Herzenberg LA; Roederer M
    Blood; 1997 Nov; 90(9):3662-72. PubMed ID: 9345051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Labelling of lymphocytes with indium 111 oxine: effect on cell surface phenotype and antibody-dependent cellular cytotoxicity.
    Signore A; Beales P; Sensi M; Zuccarini O; Pozzilli P
    Immunol Lett; 1983 Mar; 6(3):151-4. PubMed ID: 6407981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three different methods for radiolabelling human activated T lymphocytes.
    Botti C; Negri DR; Seregni E; Ramakrishna V; Arienti F; Maffioli L; Lombardo C; Bogni A; Pascali C; Crippa F; Massaron S; Remonti F; Nerini-Molteni S; Canevari S; Bombardieri E
    Eur J Nucl Med; 1997 May; 24(5):497-504. PubMed ID: 9142729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nature of the T lymphocytes in lymphocyte predominance Hodgkin's disease.
    Dargent JL; Schandene L; Kornreich A; Lespagnard L; Cochaux P; Jagodzinski R; Capel P; Velu T; Neve P
    Leuk Lymphoma; 1997 Feb; 24(5-6):545-51. PubMed ID: 9086445
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2.
    Romagnani S; Maggi E; Parronchi P; Macchia D; Del Prete GF; Rossi-Ferrini PL; Ricci M; Moretta L
    Int J Cancer; 1986 Mar; 37(3):343-9. PubMed ID: 3081452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hodgkin's disease in AIDS complex patients. Report of four cases and tissue immunologic marker studies.
    Unger PD; Strauchen JA
    Cancer; 1986 Aug; 58(4):821-5. PubMed ID: 2941139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Study on perigastric lymphatics using 111In-oxine-labeled lymphocytes].
    Hara A; Okajima K; Kuromoto N; Isozaki H; Kitamura A; Nakajima T; Ishiga N
    Nihon Geka Gakkai Zasshi; 1987 Feb; 88(2):239. PubMed ID: 3106784
    [No Abstract]   [Full Text] [Related]  

  • 38. Contribution of contaminant indium-114m/indium-114 to indium-111 oxine blood dosimetry.
    Marcus CS; Stabin MG; Watson EE; Kuperus JH
    J Nucl Med; 1985 Sep; 26(9):1091-3. PubMed ID: 3928839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of common variable immunodeficiency: identification of a subset of patients with distinctive immunophenotypic and clinical features.
    Wright JJ; Wagner DK; Blaese RM; Hagengruber C; Waldmann TA; Fleisher TA
    Blood; 1990 Nov; 76(10):2046-51. PubMed ID: 2146980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced proliferation in T lymphocytes in aged humans is predominantly in the CD8+ subset, and is unrelated to defects in transmembrane signaling which are predominantly in the CD4+ subset.
    Grossmann A; Ledbetter JA; Rabinovitch PS
    Exp Cell Res; 1989 Feb; 180(2):367-82. PubMed ID: 2521605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.